Contact Allergy in 107 Professional Ice Hockey Players
Doctor’s Notes · Life in Motion · Evidence Review
Editorial disclosure: The featured scene is an AI-created illustration of fictional people and work or activity settings. It is not a patient, diagnosis, before-and-after image or Dr. Arsy #003 treatment result.
The practical question
Contact allergy was common in this group, but allergy is not the same as a current clinically relevant rash.
This research becomes useful only when its population, denominator, design and timepoint remain attached. A percentage from a referral clinic, workforce survey or prevention program is not an individual prediction and cannot diagnose why one person’s skin changed.
Study snapshot
| Study element | Reported detail |
|---|---|
| Population | 107 Swedish professional ice hockey players from 10 top-league teams |
| Design | Cross-sectional skin examination and patch-test study |
| Timepoint | Single preseason or in-season assessment |
| Key result | About one in four players had at least one contact allergy; common reactions included Amerchol L101, nickel and oxidized limonene |
What the numbers can—and cannot—say
About one in four players had at least one contact allergy; common reactions included Amerchol L101, nickel and oxidized limonene.
The study was cross-sectional, some positives may not be relevant to equipment or symptoms, and elite Swedish players may not represent recreational athletes.
That boundary matters. Cross-sectional associations cannot show which came first. Patch-test positivity requires clinical relevance. A workplace program may combine substitution, training, gloves, washing and clinical care, so improvement cannot automatically be assigned to one component.
Turn the study into a better exposure history
Record the exact task, material or equipment, contact site, frequency, wet-work duration, glove type, cleanser, symptom timing, days away from exposure and functional effect. Compare workdays with days off without deliberately re-exposing skin. Photographs and a product or safety-data list can help a clinician or occupational-health team reconstruct the sequence.
Prevention follows a hierarchy: eliminate or substitute hazards where feasible, control splashes or aerosols, improve workflow and training, then use correctly selected protective equipment. A moisturizer can support dry-skin comfort; it cannot neutralize an allergen, corrosive chemical, contaminated water or friction hazard.
Practical questions for work, sport or school
- Was the study population similar to this person, or already selected because symptoms were present?
- Does the distribution match the suspected equipment, material, uniform or task?
- Would clinician-directed patch testing or occupational review change the plan?
- What outcome will be tracked: severity, sleep, function, absence, productivity or safe participation?
- What would trigger urgent evaluation, such as rapidly spreading redness, drainage, fever, severe pain or major functional loss?
Primary and authoritative sources
- Primary medical research record: PubMed PMID 38501375
- NIAMS: atopic dermatitis overview
- American Academy of Dermatology: skin-care guidance
- NIOSH: occupational skin-exposure recommendations
PubMed indexing is not NIH endorsement of a study’s interpretation, this article or any product.
Where a cosmetic moisturizer fits
Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003, and outside research does not become a product result. #003 is not an eczema medicine and this article makes no treatment, cure, prevention, pediatric-safety or 24-hour claim.
Bottom line
The responsible conclusion is the narrow one: preserve the denominator, comparator, timepoint and limitations, then use the study to ask better clinical and exposure-control questions rather than to promise a universal result.
Educational content only. Researchers and cited organizations do not endorse Dr. Arsy.